Single-ascending Dose Study of Kylo-12 in Healthy Subjects

NCT06783881 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Kylo-12
DRUG: Placebo

Sponsor

Kylonova (Xiamen) Biopharma co., LTD.